SCHEMBL10035680

SCHEMBL10035680

CCCCCCCCCC(=O)Nc1ccccc1S(=O)(=O)OC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CETP P11597 2/20 0.58
SOAT1 P35610 2/20 0.56
EP300 Q09472 1/20 0.52
L3MBTL1 Q9Y468 2/20 0.50
GAA P10253 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
HDAC3 O15379 3/20 0.49
HDAC1 Q13547 3/20 0.49
HDAC2 Q92769 3/20 0.49
HDAC4 P56524 2/20 0.49
HDAC7 Q8WUI4 2/20 0.49
HDAC10 Q969S8 2/20 0.49
HDAC11 Q96DB2 2/20 0.49
HDAC8 Q9BY41 2/20 0.49
HDAC6 Q9UBN7 2/20 0.49
HDAC9 Q9UKV0 2/20 0.49
HDAC5 Q9UQL6 2/20 0.49
POLB P06746 1/20 0.49
ATM Q13315 1/20 0.49
TSHR P16473 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4138486 0.85 CETP (0.62) CETPSOAT1EP300HDAC3HDAC1
SCHEMBL31612639 0.85 CETP (0.62) CETPSOAT1EP300HDAC3HDAC1
SCHEMBL10035669 0.85 CETP (0.62) CETPSOAT1EP300HDAC3HDAC1
SCHEMBL29780051 0.83 CETP (0.59) CETPSOAT1EP300L3MBTL1HDAC3
SCHEMBL10406786 0.83 CETP (0.59) CETPSOAT1EP300HDAC3HDAC1
SCHEMBL9395051 0.81 CETP (0.77) CETPSOAT1EP300HDAC3HDAC1
SCHEMBL5878480 0.81 CETP (0.77) CETPSOAT1EP300HDAC3HDAC1
SCHEMBL13688828 0.81 SMN1; SMN2 (0.39) CETPSOAT1EP300L3MBTL1POLB
SCHEMBL10961688 0.78 HDAC3 (0.77) CETPSOAT1EP300L3MBTL1GAA
SCHEMBL11902610 0.77 ALDH1A1 (0.74) CETPSOAT1EP300L3MBTL1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8110329-B2 Charge controlling agent and toner CANON KABUSHIKI KAISHA (JP) 2012-02-07 US disclosed
US-20070111125-A1 CHARGE CONTROLLING AGENT AND TONER CANON KABUSHIKI KAISHA (JP) 2007-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070111125-A1 CHARGE CONTROLLING AGENT AND TONER CA2, ACTR2, CA12 CETP 1871/4885SOAT1 1159/4885EP300 1516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.